← Eichor
Study identifier: NCT03099681 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

An Observational Study on Epithelioid Sarcoma

Condition: Epithelioid Sarcoma  ·  Sponsor: Italian Sarcoma Group

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)

This description comes directly from the study's public registry record.

Talk to the study team

Annamaria Frezza, MD  ·  003902390  ·  annamaria.frezza@istitutotumori.mi.it

Always discuss trial participation with your own doctor first.

Locations (11)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRSTMeldola, FC, ItalyRecruiting
Istituto Europeo di OncologiaMilan, MI, ItalyRecruiting
Istituto Clinico HumanitasRozzano, MI, ItalyRecruiting
Azienda Ospedaliera Universitaria Paolo GiacconePalermo, PA, ItalyRecruiting
Fondazione del Piemonte per l'Oncologia IRCC CandioloCandiolo, Torino, ItalyRecruiting
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal TumorsBologna, ItalyRecruiting
Fondazione IRCCS INT MilanoMilan, ItalyRecruiting
Irccs Istituto Oncologico Veneto (Iov)Padova, ItalyRecruiting
Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4Prato, ItalyRecruiting
Campus BiomedicoRoma, ItalyRecruiting
Istituti Fisioterapici Ospitalieri di RomaRoma, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03099681